Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1516-1520

  Hayder, Hikmat ^a   Blanden, Robert V ^a   Körner, Heinrich ^b,c   Riminton, D Sean ^b   Sedgwick, Jonathon D ^b,d   Müllbacher, Arno ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE COURSE; DNA SEQUENCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, CD; DNA, VIRAL; FEMALE; HUMANS; IMMUNITY, NATURAL; LIVER; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033179697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Horwitz, M. S. 1990. Adenoviruses. In Virology, 2nd Ed. B. N. Fields and D. M. Knipe, eds. Raven Press, New York, pp. 1723-1740.
2. Graham, F. L. 1990. Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol. 8:85.
3. Horwitz, M. S. 1990. Adenoviridae and their replication. In Virology, 2nd Ed. B. N. Fields and D. M. Knipe, eds. Raven Press, New York, pp. 1679-1721.
4. Duereksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 141:4193.
5. Shisler, J., P. Duerksen-Hughes, T. M. Hermiston, W. S. Wold, and L. R. Gooding. 1996. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70:68.
6. Wesseling, J. G., G.-J. Godeke, V. E. C. Schijns, L. Prevec, F. L. Graham, M. C. Horzinek, and P. J. M. Rottier. 1993. Mouse hepatitis virus spike and mucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J. Gen. Virol. 74:2061.
7. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1.
8. Hayder, H., and A. Müllbacher. 1996. Molecular basis of immune evasion strategies by adenovirus. Immunol. Cell Biol. 74:504.
9. Gooding, L. R., I. O. Sofola, A. E. Tollefson, P. Duerksen-Hughes, and W. S. Wold. 1990. The adeonvirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145:3080.
10. Gooding, L., T. S. Ranhein, A. E. Tollefspm, L. Aquine, P. Duerksen-Hughes, T. M. Horton, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:4114.
11. Gooding, L. R., L. Aquino, P. J. Duerksen-Hughes, D. Day, T. M. Horton, S. Yei, and W. S. M. Wold. 1991. The E1B 19,000-molecular-weight protein. J. Virol. 65:3083.
12. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.
13. Perez, C., I. Albert, K. DeFay, N. Zachariades, L. Gooding, and M. Kriegler. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-cell contact. Cell 63:251.
14. Brockhaus, M., H. J. Schoenfeld, E. J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87: 3127.
15. Thoma, B., M. Grell, K. Pfizenmaier, and P. Scheurich. 1990. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172:1019.
16. Lewis, M., L. A. Tartaglia, G. L. Bennett, G. C. Rice, G. H. Wong, C. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830.
17. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, M. Mizushima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
18. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, Jr., and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
19. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
20. Baithwaite, A. W., A. J. D. Bellett, G. E. Blair, A. Müllbacher, and X. Zhang. 1993. Human adenoviruses: genetics and immunobiology. In Viruses and the Cellular Immune Response. D. B. Thomas, ed. Marcel Dekker, New York, pp. 389-428.
21. Braithwaite. A. W., B. F. Cheetham, P. Li, C. R. Parish, L. K. Waldron-Stevens, and A. J. D. Bellett. 1983. Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J. Virol. 45:192.
22. Zhang, X., A. J. D. Bellett, R. Tha Hla, T. Voss, A. Müllbacher, and A. W. Braithwaite. 1994. Down-regulation of human adenovirus E1a by E3 gene products: evidence for translational control of E1a by E3 4.5K and/or E3 10.4K products. J. Gen. Virol. 75:1943.
23. Zhang, X. L., A. J. D. Bellett, R. Tha Hla, A. W. Braithwaite, and A. Müllbacher. 1991. Adenovirus E3 gene products interfere with the expression of the cytolytic T cell immunodominant E1a antigen. Virology 180:199.
24. Rothe, J., L. Werner, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Stienmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
25. Zheng, L., G. Fisher, R. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
26. Körner, H., M. Cook, D. S. Riminton, F. A. Lemcker, R. M. Hoek, B. Ledermann, F. Königen, B. Fazekas de St Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600.
27. Williams-Abbott, L., B. N. Walter, T. C. Cheung, C. R. Goh, A. G. Porter, and C. F. Ware. 1997. The lymphotoxin-α (LTα) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTα1β2 heterotrimeric ligand. J. Biol. Chem. 272:19451.
28. Müllbacher, A., A. J. D. Bellett, and R. Tha Hla. 1989. The murine cellular immune response to adenovirus-type 5. Immunol. Cell Biol. 67:31.
29. Bürgert, H. G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987.
30. Ginsberg, H. S., L. L. Moldawer, P. B. Seghal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651.
31. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Möller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 323:816.
32. Mestan, J., M. Brockhaus, H. Kirchner, and H. Jacobsen. 1988. Antiviral activity of tumor necrosis factor: synergism with interferons and induction of oligo-2′,5′-adenylate synthetase. J. Gen. Virol. 69:3113.
33. Wong, G. H. W., and D. V. Goeddel. 1986. Tumor necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323:819.
34. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G.-L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8:21.
35. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, and C. A. Biron. 1997. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71:9248.